FDA Issues Warning on Some Antipsychotic Drugs  
  SEARCH: Sign In | Register | Contact Us | Site Map | Home  

Resources for Food and Drug Administration (FDA)

FDA Issues Warning on Some Antipsychotic Drugs

www.washingtonpost.com

The Food and Drug Administration yesterday warned doctors that elderly patients with dementia who are being treated with an older class of antipsychotic drugs appear to be at increased risk of dying.

The agency ordered a "black box" warning placed on the labels of drugs such as haldol and thorazine, which are sometimes used to pacify demented patients who become aggressive or disturbed. A similar warning was placed on the newer class of "atypical" antipsychotic drugs three years ago.

Although information on the use of the older drugs in nursing homes and elsewhere is spotty, the regulatory agency said it thinks the older drugs were not as widely used as the newer ones, which include Risperdal, Zyprexa and Seroquel.

View the Resource



Share or bookmarklet this web page at:





Google
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home
Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved.